Exelixis
EXEL
#1727
Rank
A$17.02 B
Marketcap
A$63.50
Share price
-0.36%
Change (1 day)
8.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company